Panbela Therapeutics (PBLA) Stock Chart & Stock Price History $0.16 0.00 (0.00%) As of 08/15/2025 10:50 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Panbela Therapeutics Stock Price Performance The Panbela Therapeutics (PBLA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 57.21%, with a year-to-date return of -58.45%. In the past month, the stock has decreased 32.87%, reflecting recent market activity. As of the latest close, Panbela Therapeutics traded at $0.16 with a market cap of $767 thousand and volume of 160 shares. Receive PBLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-32.87%3 Month Performance-36.84%Year-To-Date Performance-58.45%1 Year Performance-57.21% PBLA Stock Chart for Saturday, August, 16, 2025 PBLA Chart by TradingView Panbela Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$0.16$0.16$0.16$0.16160 shs$767,000.0008/14/2025$0.16$0.16$0.16$0.168,337 shs$767,000.0008/13/2025$0.16$0.16$0.16$0.164,044 shs$767,000.0008/12/2025$0.16$0.16$0.16$0.16365 shs$767,000.0008/11/2025$0.16$0.16$0.16$0.1619,106 shs$767,000.0008/08/2025$0.16$0.16$0.16$0.16172 shs$767,000.0008/07/2025$0.16$0.16$0.16$0.16172 shs$767,000.0008/06/2025$0.16$0.16$0.16$0.162,280 shs$767,000.0008/05/2025$0.16$0.16$0.16$0.161,658 shs$767,000.0008/04/2025$0.17$0.16-7.12%$0.17$0.163,411 shs$767,000.00 Get the Latest News and Ratings for PBLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$0.17$0.17$0.17$0.17362 shs$825,000.0007/31/2025$0.16$0.17+7.66%$0.17$0.17362 shs$825,000.0007/30/2025$0.16$0.16$0.16$0.161,299 shs$767,000.0007/29/2025$0.16$0.16$0.16$0.161,001 shs$767,000.0007/28/2025$0.16$0.16$0.16$0.161,168 shs$767,000.0007/25/2025$0.16$0.16$0.16$0.16497 shs$767,000.0007/24/2025$0.16$0.16$0.16$0.0515,996 shs$767,000.0007/23/2025$0.16$0.16$0.16$0.1614,143 shs$767,000.0007/22/2025$0.16$0.16$0.16$0.164,679 shs$767,000.0007/21/2025$0.16$0.16-1.31%$0.17$0.1614,610 shs$767,000.0007/18/2025$0.19$0.16-13.93%$0.16$0.102,970 shs$777,000.0007/17/2025$0.24$0.19-20.96%$0.22$0.1622,141 shs$903,000.0007/16/2025$0.24$0.24-1.75%$0.25$0.1738,267 shs$1.14 million07/15/2025$0.24$0.24+1.18%$0.24$0.2310,486 shs$1.16 million Related Companies Redhill Biopharma Stock Chart CNS Pharmaceuticals Stock Chart Aravive Stock Chart Lipella Pharmaceuticals Stock Chart Qualigen Therapeutics Stock Chart SciSparc Stock Chart PainReform Stock Chart PMGC Stock Chart Enveric Biosciences Stock Chart Heatwurx Stock Chart Receive PBLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PBLA) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Panbela Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access